已收盤 08-08 16:00:00 美东时间
-0.050
-0.26%
Titan Pharmaceuticals announced the completion of a private placement of 60,000 shares of its Series C Convertible Preferred Stock to Blue Harbour Asset Management for $600,000 at a conversion price of $3.40. The transaction includes a beneficial ownership blocker limiting Blue Harbour to a maximum of 19.99% of the Company's outstanding common stock. The shares were sold under Regulation S and are subject to a registration rights agreement. Addit...
06-27 20:05
潜在涨幅1562.13%!Cingulate获Ascendiant Capital升目标价至61美元,维持"买入"评级
05-28 09:04
Analysts' ratings for Titan Machinery (NASDAQ:TITN) over the last quarter vary ...
05-28 06:01
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1132955525493317632.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Craig-Hallum:上调PLAYSTUDIOS(MYPS)评级至"买入",目标价从2美元升至3美元</p> <p>• Leerink Partners:上调Fulcrum Therapeutics(FULC)评级至"
05-24 08:40
Titan Machinery shares are trading higher after the company reported Q1 financi...
05-22 20:14
Gainers Rain Enhancement (NASDAQ:RAIN) shares rose 11.1% to $6.0 during Thursd...
05-22 20:09
Titan Machinery (NASDAQ:TITN) affirms FY2026 Adj EPS guidance from $(2.00)-$(1.25) to $(2.00)-$(1.25) vs $(1.80) analyst estimate..
05-22 18:57
Titan Machinery (NASDAQ:TITN) reported quarterly losses of $(0.58) per share which beat the analyst consensus estimate of $(0.91) by 36.26 percent. This is a 241.46 percent decrease over earnings of $0.41 per share from
05-22 18:47
Titan Machinery press release (NASDAQ:TITN): Q1 GAAP EPS of -$0.58. Revenue of $594.3M (-5.5% Y/Y). EBITDA in the first quarter of fiscal 2026 was $2.6 million, compared to $30.9 million in the first ...
05-22 18:46
Companies Reporting Before The Bell • Kanzhun (NASDAQ:BZ) is projected to repor...
05-22 16:32